Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VOLTAIRE-RA: BI 695501 vs Adalimumab in Rheumatoid Arthritis
NCT02137226Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2015
- Primary completion
- Mar 2016
- Modality
- Monoclonal Antibodies
- Countries
- 15
01
Overview
A Phase 3 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Boehringer Ingelheim. Started Jan 2015; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02137226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02137226.